Divis Labs net profit up 13 percent at Rs 557 crore in Q1
New Delhi: Drug maker Divi's Laboratories on Saturday posted a 13 percent increase in its consolidated net profit at Rs 557 crore for the first quarter ended June 30, 2021.The company had reported a net profit of Rs 492 crore in the April-June quarter of the previous fiscal.Total income rose to Rs 1,997 crore in the first quarter as compared with Rs 1,748 crore in the June quarter of...
New Delhi: Drug maker Divi's Laboratories on Saturday posted a 13 percent increase in its consolidated net profit at Rs 557 crore for the first quarter ended June 30, 2021.
The company had reported a net profit of Rs 492 crore in the April-June quarter of the previous fiscal.
Total income rose to Rs 1,997 crore in the first quarter as compared with Rs 1,748 crore in the June quarter of 2020-21 fiscal, Divi's Laboratories said in a regulatory filing.
Read also: Sun Pharma reports consolidated net profit of Rs 1,444 crore in Q1
Forex gain for the current quarter stood at Rs 20 crore as against a gain of Rs 5 crore during the corresponding quarter of the last year, it added.
Read also: Piramal net profit up 8 percent to Rs 534 crore in Q1
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd